A Multicenter, Rand., Double-Blind, Parallel-Group, Pbo-Controlled Study of the Efficacy and Safety of SEROQUEL XR [quetiapine] Compared With Pbo as an Adjunct to Treatment in Patients With Generalized Anxiety Disorder Who Demonstrate Partial or No Response to a SSRI or SNRI Alone or in Combination With a Benzo.
Phase of Trial: Phase III
Latest Information Update: 13 Mar 2011
At a glance
- Drugs Quetiapine (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 08 Jul 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 08 Jul 2009 Trial phase changed from II to III as reported by ClinicalTrials.gov.
- 30 Oct 2007 New trial record.